Cargando…
Cell type–dependent bimodal p53 activation engenders a dynamic mechanism of chemoresistance
Studies of drug resistance mostly characterize genetic mutation, and we know much less about phenotypic mechanisms of drug resistance, especially at a quantitative level. p53 is an important mediator of cellular response to chemotherapy, but even p53 wild-type cells vary in drug sensitivity for uncl...
Autores principales: | Yang, Ruizhen, Huang, Bo, Zhu, Yanting, Li, Yang, Liu, Feng, Shi, Jue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300403/ https://www.ncbi.nlm.nih.gov/pubmed/30585287 http://dx.doi.org/10.1126/sciadv.aat5077 |
Ejemplares similares
-
DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control
por: Chen, Xi, et al.
Publicado: (2013) -
Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response
por: Choi, Minsoo, et al.
Publicado: (2017) -
TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner
por: Jiang, Jie, et al.
Publicado: (2021) -
A p53/lnc‐Ip53 Negative Feedback Loop Regulates Tumor Growth and Chemoresistance
por: Zhang, Li‐Zhen, et al.
Publicado: (2020) -
Engendered Economics: Incorporating Diversity into Political Economy
por: Mutari, Ellen
Publicado: (2016)